ZeroHarm Sciences: Financial Breakdown
Decoding financial health metrics of ZeroHarm Sciences
Total Revenue₹26.1 Cr47%Prev. FY
Total Expenses₹25.9 Cr38%Prev. FY
Profit After Tax₹33.0 Lakh133%Prev. FY
Total Assets₹56.1 Cr104%Prev. FY
Net Profit Margin1.3%122%Prev. FY
FAQs on Financials of ZeroHarm Sciences
Yes. In FY25, ZeroHarm Sciences reported a profit after tax of ₹1.5 Cr, making it profitable.
ZeroHarm Sciences's revenue grew 130.3% year-on-year, from ₹17.6 Cr in FY24 to ₹40.6 Cr in FY25.
ZeroHarm Sciences's estimated EBITDA for FY25 was ₹4.9 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, ZeroHarm Sciences posted revenue of ₹40.6 Cr (up 130.3% YoY) and a profit after tax of ₹1.5 Cr. Explore the full financials of ZeroHarm Sciences here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links